切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2015, Vol. 11 ›› Issue (02) : 261 -264. doi: 10.3877/cma.j.issn.1673-5250.2015.02.025

所属专题: 文献

综述

NovaSure子宫内膜去除术治疗异常子宫出血临床研究进展
董虹1, 王燕1,*,*()   
  1. 1. 430070 武汉,湖北省妇幼保健院妇科
  • 收稿日期:2014-09-13 修回日期:2015-02-28 出版日期:2015-04-01
  • 通信作者: 王燕

Progress in clinical treatment of abnormal uterine bleeding by NovaSure endometrial ablation

Hong Dong1, Yan Wang1()   

  1. 1. Department of Gynecology, Hubei Provincial Maternal and Child Health Care Hospital, Wuhan 430070, Hubei Province, China
  • Received:2014-09-13 Revised:2015-02-28 Published:2015-04-01
  • Corresponding author: Yan Wang
  • About author:
    Corresponding author: Wang Yan, Email:
引用本文:

董虹, 王燕. NovaSure子宫内膜去除术治疗异常子宫出血临床研究进展[J]. 中华妇幼临床医学杂志(电子版), 2015, 11(02): 261-264.

Hong Dong, Yan Wang. Progress in clinical treatment of abnormal uterine bleeding by NovaSure endometrial ablation[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2015, 11(02): 261-264.

NovaSure子宫内膜去除术作为治疗异常子宫出血(AUB)的第二代新型方法,较其余方法具有治疗时间最短,操作简单且不需预处理,闭经率高、复治率低等优点。NovaSure独有的设计能精确控制整个宫腔子宫内膜的切除深度及面积,提高手术安全性及有效性,且NovaSure子宫内膜去除术的各类术后并发症发生率极低。目前,NovaSure在国内的应用日趋广泛。笔者拟就NovaSure子宫内膜去除术治疗AUB的临床应用及进展进行综述。

NovaSure endometrial ablation is the second generation method and a new treatment for abnormal uterine bleeding(AUB). Compare to other strategies, it has many advantages, such as shortest time of operation, simple operation, without preoperative pretreatment, high amenorrhea rates and low rates of reintervention after NovaSure endometrial ablation.In addition, its unique design can precisely control the depth of ablation and the area of the entire uterine endometrium, and improve the safety and efficacy of operation. It's postoperative complication rates are very low.Currently, the application of NovaSure endometrial ablation has become increasingly widespread in the domestic.This article focuses on clinical applications and progress in treatment of AUB by NovaSure endometrial ablation.

[1]
赵春梅,孙小丽,罗喜平.阻抗控制子宫内膜切除术治疗子宫异常出血的临床应用与进展[J].中华妇幼临床医学杂志:电子版,2013,9(1):117–119.
[2]
张以文.FIGO关于月经异常相关术语的共识和异常子宫出血病因的新分类系统[J].国际妇产科学杂志,2013,40(2):105–107.
[3]
Munro MG,Critchley HO,Fraser IS,et al.The FIGO classification of causes of abnormal uterine bleeding in the reproductive years[J].Fertil Steril,2011,95 (7):2204–2208.
[4]
Gallinat A. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients[J].J Reprod Med,2007,52(6):467–472.
[5]
Kleijn JH,Engels R,Bourdrez P,et al.Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation[J]. BJOG,2008,115(2):193–198.
[6]
Kalkat RK,Cartmill RS. NovaSure endometrial ablation under local anaesthesia in an outpatient setting:an observational study[J].J Obstet Gynaecol, 2011,31(2):152–155.
[7]
Asgari Z,Moini A,Samiee H,et al. Endometrial ablation with the NovaSure system in Iran[J].Int J Gynaecol Obstet,2011,114(1):73–75.
[8]
Baskett TF,Clough H,Scott TA.NovaSure bipolar radiofrequency endometrial ablation:report of 200 cases[J].J Obstet Gynaecol Can,2005,27(5):473–476.
[9]
Cooper J,Gimpelson RJ.Summary of safety and effectiveness data from FDA:a valuable source of information on the performance of global endometrial ablation devices[J].J Reprod Med,2004,49(4):267–273.
[10]
Sabbah R,Desaulniers G.Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease:12-month follow-up results of a prospective,single-arm clinical study[J].J Minim Invasive Gynecol,2006,13(5):467–471.
[11]
王子静,杨永秀.诺舒阻抗控制系统子宫内膜去除术的临床应用及进展[J].国际生殖健康/计划生育杂志,2014,33(2):124–127.
[12]
El-Nashar SA,Hopkins MR,Barnes SA, et al. Health-related quality of life and patient satisfaction after global endometrial ablation for menorrhagia in women with bleeding disorders:a follow-up survey and systematic review[J].Am J Obstet Gynecol,2010,202(4):348.e1–e7.
[13]
孙小丽,曾俐琴,张华明,等.诺舒阻抗控制系统治疗月经过多的临床研究[J].中华妇产科杂志,2013,48(1):55–57.
[14]
Khan Z,EI-Nashar SA,Hopkins MR,et al.Efficacy and safety of global endometrial ablation after cesarean delivery:a cohort study[J].Am J Obstet Gynecol, 2011,205(5):450.el–e4.
[15]
Shavell VI,Diamond MP,Senter JP,et al. Hysterectomy subsequent to endometrial ablation[J].J Minim Invasive Gynecol,2012,19(4):459–464.
[16]
Penninx JP,Mol BW,Engels R,et al. Bipolar radiofrequency endometrial ablation compared with hydrothermablation for dysfunctional uterine bleeding:a randomized controlled trial[J].Obstet Gynecol,2010,116(4):819–826.
[17]
Gimpelson RJ.Ten-year literature review of global endometrial ablation with the NovaSure device[J].Int J Womens Health,2014,6:269–280.
[18]
Clark TJ,Samuels N,Malick S,et al.Bipolar radiofrequency compared with thermal balloon endometrial ablation in the office:a randomized controlled trial[J]. Obstet Gynecol,2011,117(5):1228.
[19]
Daniels JP,Middleton LJ,Champaneria R,et al.Second generation endometrial ablation techniques for heavy menstrual bleeding:network meta-analysis[J]. BMJ,2012,344:e2564.
[20]
Lukes AS,McBride RJ,Herring AH,et al.Improved premenstrual syndrome symptoms after NovaSure endometrial ablation[J].J Minim Invasive Gynecol,2011,18(5):607–611.
[21]
ACOG Committee on Practice Bulletins-Gynecology.ACOG Practice Bulletin No.81: endometrial ablation[J].Obstet Gynecol,2007,109(5):1233–1248.
[22]
Smith SE,Bacher-Lind L.Pregnancy outcomes following a NovaSure○R endometrial ablation procedure[J].J Minim Invasive Gynecol,2012,19(6):S21.
[1] 陈兰, 曹佩霞, 孔彩霞. 诺舒阻抗子宫内膜切除系统治疗异常子宫出血后存在的问题及防治[J]. 中华妇幼临床医学杂志(电子版), 2017, 13(02): 214-217.
[2] 张生澎, 尚宏瑜, 李茹苑, 张露平, 杨保军, 冯力民. 双极射频阻抗控制系统联合左炔诺孕酮宫内节育系统治疗异常子宫出血的临床研究[J]. 中华腔镜外科杂志(电子版), 2023, 16(02): 101-105.
[3] 赵辉, 李海霞, 杨保军, 冯力民. 诺舒子宫内膜去除术治疗异常子宫出血的远期疗效分析[J]. 中华腔镜外科杂志(电子版), 2021, 14(04): 211-216.
[4] 张露平, 尚宏瑜, 李文君, 赵辉, 郭蕾, 张生澎, 冯力民. 异常子宫出血NovaSure子宫内膜去除术后再干预的危险因素分析[J]. 中华腔镜外科杂志(电子版), 2020, 13(04): 229-232.
[5] 刘莹莹, 姚群, 范颖. 热球子宫内膜去除术联合曼月乐治疗异常子宫出血的临床疗效观察[J]. 中华临床医师杂志(电子版), 2022, 16(07): 661-666.
阅读次数
全文


摘要